Sanjula D Singh,Cyprien A Rivier,Keren Papier,Zeina Chemali,Leidys Gutierrez-Martinez,Livia Parodi,Ernst Mayerhofer,Jasper Senff,Santiago Clocchiatti-Tuozzo,Courtney Nunley,Amy Newhouse,An Ouyang,M Brandon Westover,Rudolph E Tanzi,Ronald M Lazar,Aleksandra Pikula,Sarah Ibrahim,H Bart Brouwers,Virginia J Howard,George Howard,Nirupama Yechoor,Thomas Littlejohns,Kevin N Sheth,Jonathan Rosand,Gregory Fricchione,Christopher D Anderson,Guido J Falcone

Abstract:Introduction: The 21-point Brain Care Score (BCS) is a novel tool designed to motivate individuals and care providers to take action to reduce the risk of stroke and dementia by encouraging lifestyle changes. Given that late-life depression is increasingly recognized to share risk factors with stroke and dementia, and is an important clinical endpoint for brain health, we tested the hypothesis that a higher BCS is associated with a reduced incidence of future depression. Additionally, we examined its association with a brain health composite outcome comprising stroke, dementia, and late-life depression. Methods: The BCS was derived from the United Kingdom Biobank baseline evaluation in participants with complete data on BCS items. Associations of BCS with the risk of subsequent incident late-life depression and the composite brain health outcome were estimated using multivariable Cox proportional hazard models. These models were adjusted for age at baseline and sex assigned at birth. Results: A total of 363,323 participants were included in this analysis, with a median BCS at baseline of 12 (IQR: 11-14). There were 6,628 incident cases of late-life depression during a median follow-up period of 13 years. Each five-point increase in baseline BCS was associated with a 33% lower risk of incident late-life depression (95% CI: 29%-36%) and a 27% lower risk of the incident composite outcome (95% CI: 24%-30%). Discussion: These data further demonstrate the shared risk factors across depression, dementia, and stroke. The findings suggest that a higher BCS, indicative of healthier lifestyle choices, is significantly associated with a lower incidence of late-life depression and a composite brain health outcome. Additional validation of the BCS is warranted to assess the weighting of its components, its motivational aspects, and its acceptability and adaptability in routine clinical care worldwide.

Corrigendum: The predictive validity of a Brain Care Score for late-life depression and a composite outcome of dementia, stroke, and late-life depression: data from the UK Biobank cohort

Corrigendum: The predictive validity of a Brain Care Score for dementia and stroke: data from the UK Biobank cohort

The predictive validity of a Brain Care Score for late-life depression and a composite outcome of dementia, stroke, and late-life depression: data from the UK Biobank cohort

Abstract WMP19: A Brain Care Score for Risk of Late-Life Depression: Data From the UK Biobank Cohort

Corrigendum: Prioritizing determinants of cognitive function in healthy middle-aged and older adults: insights from a machine learning regression approach in the Canadian longitudinal study on aging

Corrigendum: Development and initial validation of a clinical measure to assess symptoms of post-stroke depression in stroke patients at the rehabilitation stage

Abstract WMP18: A Brain Care Score for Dementia and Stroke: Data From the UK Biobank Cohort

Corrigendum: Loneliness and global cognitive functioning in racially and ethnically diverse US midlife and older adults

Correction: Linking Dementia Pathology and Alteration in Brain Activation to Complex Daily Functional Decline During the Preclinical Dementia Stages: Protocol for a Prospective Observational Cohort Study

Brain Care Score and Neuroimaging Markers of Brain Health in Asymptomatic Middle-Age Persons

Corrigendum: Early-Onset Depression in Stroke Patients: Effects on Unfavorable Outcome 5 Years Post-stroke

Corrigendum: The Aging Slopes of Brain Structures Vary by Ethnicity and Sex: Evidence From a Large Magnetic Resonance Imaging Dataset From a Single Scanner of Cognitively Healthy Elderly People in Korea

Corrigendum: genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses

Corrigendum: Blood pressure control and risk of post-stroke dementia among the elderly: A population-based screening study

Corrigendum: Associations between blood-based biomarkers of Alzheimer's disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau

Correction: Correlation Between Remote Symptom Reporting by Caregivers and Adverse Clinical Outcomes: Mixed Methods Study

Correction: Comprehensive Symptom Prediction in Inpatients With Acute Psychiatric Disorders Using Wearable-Based Deep Learning Models: Development and Validation Study

Corrigendum to “association Between GAB2 Haplotype and Higher Glucose Metabolism in Alzheimer's Disease-Affected Brain Regions in Cognitively Normal APOEε4 Carriers” [neuroimage 54/3 (2011) 1896–1902]

Psychiatric comorbid disorders of cognition: a machine learning approach using 1175 UK Biobank participants

Corrigendum: Longitudinal Associations of Stroke With Cognitive Impairment Among Older Adults in the United States: A Population-Based Study

Corrigendum: The association between metabolic disturbance and cognitive impairments in early-stage schizophrenia